Lv4
550 积分 2024-06-15 加入
Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial
1个月前
已完结
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update
1个月前
已完结
Harnessing big data to characterize immune-related adverse events
1个月前
已完结
Diagnosis and management of immune mediated liver injury from checkpoint inhibitors
5个月前
已完结
Immune checkpoint inhibitors and acute kidney injury
5个月前
已完结
Immune Checkpoint Inhibitors — The Need for Innovation
9个月前
已完结
皖公网安备34019202002308
